Pages that link to "Q41134105"
Jump to navigation
Jump to search
The following pages link to Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel (Q41134105):
Displaying 2 items.
- Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer (Q89456704) (← links)
- An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress? (Q90353123) (← links)